Valid Consent for Genomic Epidemiology in Developing Countries

Chokshi, D.A.; Thera, M.A.; Parker, M.; Diakite, M.; Makani, J.; Kwiatkowski, D.P.; Doumbo, O.K.

dc.contributor.author	Chokshi, D.A.
dc.contributor.author	Thera, M.A.
dc.contributor.author	Parker, M.
dc.contributor.author	Diakite, M.
dc.contributor.author	Makani, J.
dc.contributor.author	Kwiatkowski, D.P.
dc.contributor.author	Doumbo, O.K.
dc.date.accessioned	2013-04-04T12:51:29Z
dc.date.available	2013-04-04T12:51:29Z
dc.date.issued	2007
dc.identifier.citation	Chokshi, D. A., Thera, M. A., Parker, M., Diakite, M., Makani, J., Kwiatkowski, D. P., & Doumbo, O. K. (2007). Valid consent for genomic epidemiology in developing countries. PLoS medicine, 4(4), e95.
dc.identifier.other	doi:10.1371/journal.pmed.0040095
dc.identifier.uri	http://hdl.handle.net/123456789/783
dc.description.abstract	Genomic research has the potential to improve global health by elucidating basic mechanisms of disease, susceptibility, and resistance, thereby guiding the development of preventive interventions [1]. Recently developed methods for exploring how human genetic variation affects resistance are likely to provide strategic clues about vaccine development for researchers working on malaria, HIV, tuberculosis, and other diseases of the developing world	en_GB
dc.language.iso	en	en_GB
dc.publisher	PLoS Medicine
dc.relation.ispartofseries	PLoS Medicine 4(4): e95.
dc.subject	Valid Consent	en_GB
dc.subject	Genomic Epidemiology	en_GB
dc.subject	Developing Countries	en_GB
dc.title	Valid Consent for Genomic Epidemiology in Developing Countries	en_GB
dc.type	Article	en_GB